Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00111696
Status:
COMPLETED
Last Update Posted:
2012-03-14
First Post:
2005-05-24
Brief Title:
Study of the Tumor Saturation and Biological Activity of MEDI-522 Abergrin in Patients With Advanced Malignant Melanoma
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Organization Data
Organization:
MedImmune LLC
Class:
INDUSTRY
Study ID:
MI-CP121
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedImmune LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Lawrence Danel-Moore MD PhD VP Clin Dev
Old Organization:
MedImmune LLC